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Reading numbers aloud as a tool 
for the evaluation of breathlessness 
in Polish cancer patients
Abstract
Background: The aim of the study was to verify the usefulness of the test of reading numbers aloud 
(ReNA) in the assessment of the intensity of dyspnoea at rest or on minimal exertion in Polish patients with 
advanced cancer. 
Material and methods: The study group included patients with advanced cancer who were breathless at 
rest or on minimal exertion. A modified Borg scale, a numeric rating scale (NRS) and a visual analogue scale 
(VAS) to assess breathlessness and peak expiratory flow (PEF) were performed. Patients then read aloud from 
a page containing a grid of numbers as quickly and clearly as they could for 60 seconds. It was intended 
to repeat the reading five times. The maximal amount of numbers read during the test (NNmax) and the 
maximal numbers read per breath (NN/Bmax) were noted. 
Results: Thirty-one patients with evidence of cancer participated in the study. However, for statistical analy-
sis we included 28 patients (17 males, mean age 64.1 ± SD = 8.8) who were able to read numbers aloud 
at least once. The mean value for the modified Borg scale was 4.07 ± 1.89, NRS 5.75 ± 2.37 and VAS 
5.11 ± 2.34. The average value for PEF was 183.26 ± 89.97. Twelve patients (42.86%) were unable to 
complete all five readings due to tiredness and fatigue. The mean value for the NNmax was 50.39 ± 29.93 
and for NN/Bmax was 2.92 ± 2.45. No correlation was observed between the results for NRS, VAS or PEF 
and NNmax or NN/Bmax. Only the modified Borg scale correlated moderately with NNmax and NN/Bmax 
(R = –0.52 and R = –0.44, respectively). 
Conclusion: The ReNA seems to be a useful tool for assessing the intensity of dyspnoea at rest or on minimal 
exertion in Polish patients with advanced cancer. However, fatigue and tiredness due to the reading were 
a problem for almost half of the advanced cancer patients, who were unable to complete the whole test.
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Introduction
Breathlessness is a common symptom in many 
chronic illnesses, including both malignant and 
non-malignant conditions. In cancer it may be caused 
by the tumour itself, oncological treatment, complica-
tions of the debilitated state or concomitant disease. 
The incidence of breathlessness is especially high 
during the last six weeks of life and assessed in dif-
ferent studies as between 50–70% [1]. Management 
of dyspnoea is aimed first at reversing the underlying 
cause; however, if this is not possible or not satis-
factorily effective, symptomatic treatment might be 
required. This usually consists of non-pharmacological 
and pharmacological methods, such as opioids, anxi-
olytics, bronchodilators or corticosteroids [2]. Their 
efficacy in cancer patients is assessed by subjective 
measures, although it is still unclear which objective 
parameters might be helpful.  In patients who are 
breathless on exertion, the Six-Minute Walk Test or 
Shuttle Walking is usually used as a tool for objective 
evaluation [3, 4]. However, this cannot be imple-
mented in many advanced cancer patients, who are 
too weak to march or who are short of breath at rest 
or on minimum exertion. For this population, Wilcock 
et al. proposed reading numbers aloud (ReNA) for 
measuring the limiting effect of breathlessness [5]. 
Our pilot study, described in this paper, was presented 
first during the 19th Annual Congress of the European 
Respiratory Society in Vienna in 2009 [6]. We aimed 
to verify the usefulness of ReNA in the assessment 
of the intensity of dyspnoea at rest or on minimal 
exertion in Polish patients with advanced cancer. We 
also investigated the relation of ReNA to the chosen 
screening spirometric parameter and to some subjec-
tive measurement scales.  
Methodology
The study was approved by the Ethical Committee 
of the Medical University of Gdansk. The patients in-
cluded in the study were treated either in the Lung 
Disease Department of the University Hospital in 
Gdansk or in the Hospice Pallotinum in Gdansk. The 
patients suffered from cancer and were breathless at 
rest or on minimal exertion. All participants gave 
written informed consent. The study duration per 
patient was one day. Patients were asked to rate the 
severity of breathlessness by using a Numerical Rat-
ing Scale (ranging from 0 = “no breathlessness” to 
10 = “breathlessness as bad as you can imagine”), 
a continuous Visual Analogue Scale (0–100 mm), and 
a modified Borg Scale [7]. The last scale consists of 
a vertical scale labelled from 0 to 10 with a corre-
sponding verbal expression of increasing perceived 
sensation intensity, from “nothing at all” to “maxi-
mal” [7]. Apart from subjective measures, a measure-
ment of peak expiratory flow (PEF) was performed 
with the subjects, standing as the best of three 
recordings (Mini-Wright Peak Flow Meter, Clement 
Clarke International UK).  
While seated, the patients read numbers aloud 
(ReNA) from a page containing a grid of num-
bers as quickly and clearly as they could for 60 sec-
onds. The amount of numbers read during the test 
and the numbers read per breath were noted. It 
was intended to repeat the reading five times to 
choose the maximum values. 
Results
Thirty-one patients (18 males, mean age 
63.6 ± SD = 7.78) with evidence of cancer partici-
pated in the study (Table 1). In one case we included 
two sets of measurement results as the patient 
was referred to the Lung Disease Department twice 
(as patient no. 2 in June 2007 and as patient no. 11 
in December 2007). Twenty-nine patients were diag-
nosed as having primary or secondary lung tumours, 
the other two had breast cancer. Seven patients also 
had obstructive airways disease. All complained of 
breathlessness that limited their daily activities. None 
was limited by dysarthria or cognitive impairment.
The concept of the reading numbers aloud test 
was easily understood by all participants. 
Four patients (nos. 9, 12, 18 and 25 in Table 1) 
were unable to do any reading at all due to severe 
weakness. All four assessed their breathlessness ac-
cording to the modified Borg, NRS and VAS scales; 
two of them (nos. 9 and 12) were also able to per-
form a PEF measurement.  However, for statistical 
analysis we included only 28 patients (17 males, 
mean age 64.1 ± SD = 8.8) who were able to read 
numbers aloud at least once. One patient from 
this group (no. 4 in Table 1) did not perform a PEF 
due to the unexpected breakdown of the equipment. 
The mean value for the modified Borg scale in 
the study group (n = 28) was 4.07 ± 1.89; NRS 
5.75 ± 2.37; and VAS 5.11 ± 2.34 (Table 2). The 
average value for PEF (n = 27) was 183.26 ± 89.97. 
Twelve patients (42.86%) were unable to com-
plete all five readings due to tiredness and fatigue. 
Two patients had already stopped after the first, 
another after the second reading. Eight others re-
signed from ReNA after the third reading, the other 
patient after the fourth. 
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The mean value for the maximum amount of num-
bers read over 60 seconds (NNmax) was 50.39 ± 29.93 
and for the maximum amount of numbers read per 
breath (NN/Bmax) was 2.92 ± 2.45 (Table 2). 
No learning effect was observed and the mean 
values for NN and NN/B for all five readings did not 
differ significantly (Table 2; Figures 1 and 2).
No correlation was observed between the re-
sults for NRS, VAS or PEF and NNmax or NN/Bmax 
(Table 3). Only the modified Borg scale correlated 
moderately with NNmax and NN/Bmax (R = –0.52 
and R = –0.44, respectively; p < 0.05; Spearman 
correlation test). 
Discussion
In this pilot study we assessed the use of ReNA to 
measure the limiting effect of breathlessness in Polish 
advanced cancer patients who were breathless at 
rest or on minimal exertion. The concept of ReNA 
was easily understood and simple to perform for the 
study participants. Contrary to Wilcock et al. [5], we 
did not observe a learning effect with an increase in 
NN and NN/B over the five readings and the first read-
ing did not differ from the second or third. Instead, 
we noticed a clear “fatigue effect”. Indeed, severe 
fatigue and tiredness due to the reading was the 
main reason why almost 43% of the patients were 
unable to complete the test. We cannot exclude 
the possibility that in some patients with advanced 
cancer, dyspnoea may be a clinical expression of the 
syndrome of overwhelming fatigue that is highly 
prevalent in this population. 
Neither NRS nor VAS was related to the mean 
values of NNmax and NN/Bmax. The striking observa-
tion was that some patients assessed the severity of 
their breathlessness as very low according to VAS or 
NRS, but were not able to finish even the first read-
Table 2. Results of the ReNA test  
n Mean Minimum Maximum SD
Age 28 64.07 50.0 82.0 8.80
NRS 28 5.75 1.0 10.0 2.37
Borg 28 4.07 1.0 10.0 1.89
VAS 28 5.11 3.4 10.0 2.34
PEF 27 183.26 70.0 400.0 89.97
NNmax 28 50.39 11.0 145.0 29.93
NN1 28 43.89 11.0 113.0 21.91
NN2 26 44.88 10 115 24.54
NN3 25 49.36 18 145 31.6
NN4 17 51.23 22 109 22.07
NN5 16 51.18 20 107 21.87
NN/Bmax 28 2.92 0.5 11.3 2.45
NN/B1 28 2.52 0.5 11.3 2.27
NN/B2 26 2.16 0.26 6.7 1.44
NN/B3 25 2.66 0.43 10.35 2.41
NN/B4 17 2.83 0.81 9.9 2.14
NN/B5 16 2.82 0.76 9.72 2.21
SD — standard deviation
Table 3. Correlations between NRS, Borg scale, VAS 
or PEF and the maximal amount of numbers and 
amount of numbers per breath 
NRS 
(n = 28)
VAS 
(n = 28)
Borg 
(n = 28)
PEF 
(n = 27)
NNmax –0.21 –0.35 –0.52* 0.02
NN/Bmax –0.1 –0.27 –0.44* –0.02
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ing, as they became extremely exhausted or could 
not catch a breath (see Table 1, f.ex. patient no. 9 or 
18). Among the tests for the subjective evaluation 
of breathlessness intensity that we used, only the 
modified Borg scale correlated moderately with ReNA 
parameters. The Borg Scale was thought to be more 
convenient for interindividual comparisons because 
of the established categories, while VAS or NRS 
allow each subject to establish their own interval 
assessment.  
The mean NNmax and NN/Bmax did not cor-
relate with PEF. It has been shown previously that 
spirometry cannot be a reliable guide to a subjec-
tive level of breathlessness as measured by VAS in 
advanced cancer patients [8]. Interestingly, spirom-
etry was shown to be less closely correlated with 
exercise tolerance in patients with chronic bron-
chitis than measures of psychological factors [9]. 
Dyspnoea is a complex syndrome and different 
studies have pointed to the need for the proper 
Figure 1. Mean amount of numbers (± SD) read by the patients. R — reading; n — number of patients
Figure 2. Mean amount of numbers read per breath (± SD) by the patients. R — reading; n — number of patients
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assessment of related bio-psycho-social-spiritual 
factors and the comprehensive management of 
breathlessness [10]. 
If different tools evaluate different aspects of 
dyspnoea, then we should methodically select the 
most appropriate scale for measuring breathless-
ness depending on the context and purpose. The 
NRS, VAS or modified Borg scale seem the most suit-
able for measuring how patients assess the severity 
of breathlessness.  However, some basic questions to 
be answered are whether the breathlessness might 
be measured at rest or on exertion and how this exer-
tion which makes a patient breathless can be defined. 
There is a need to develop a standardized test of 
the impact of breathlessness on functional capacity 
in advanced cancer patients. The Shuttle Walking 
Test has proved to be a reproducible method of 
evaluating such an effect in mobile patients whose 
clinical condition is stable [4]. However, it cannot be 
implemented in patients too frail to walk or who are 
breathless on minimal exertion, such as talking.  For 
patients with cancer of WHO performance status 3 
or 4, two other tests should probably be selected: 
upper limb exercise [11] and ReNA [5]. The latter 
might be seen as a form of exercise test for measur-
ing the limiting effect of breathlessness if patients are 
breathless on minimum exertion or at rest. 
In conclusion, we have shown that the measure-
ment of the amount of numbers read over 60 sec-
onds and the amount of numbers per breath was eas-
ily understood by Polish patients, practical and highly 
acceptable. However, fatigue and tiredness due to 
the reading were a problem for almost half of the 
advanced cancer patients, who were unable to com-
plete the whole test. 
Future study should assess the reproducibility 
and sensitivity of ReNA for Polish cancer patients.  
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